Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - China Biologic Products Holdings, Inc. | exhibit99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report (Date of Earliest event Reported): July 15, 2011
CHINA BIOLOGIC PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 001-34566 | 75-2308816 |
| (State or other jurisdiction of
incorporation or organization) |
(Commission File No.) | (IRS Employer ID No.) |
| No. 14 East Hushan Road, | ||
| Tai'an City, Shandong, 271000 | ||
| People's Republic of China | ||
| (Address of Principal Executive Offices) | ||
86-538 -620-2306
Registrant's telephone number,
including area code
____________________________________________________________
(Former
name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
Item 8.01. Other Events
On July 15, 2011, China Biologic Products, Inc. issued a press release relating to the revised “Plan for Guizhou Provincial Blood Collection Institutional Setting (2011-2014)” issued by the Guizhou Provincial Health Bureau. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
|
Exhibit No. |
Description |
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: July 15, 2011
CHINA BIOLOGIC PRODUCTS, INC.
By: /s/ Chao Ming Zhao
Chao Ming Zhao
Chief Executive Officer
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
|
|